Form 4 for RPRX Royalty Pharma plc
Accepted 2024-05-16 00:00:00 ET · period of report 2024-05-13 · accession 0001802768-24-000023 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2024-05-16 | 2024-05-13 | RPRX | Hite Christopher | EVP, Vice COB | C - Cnv Deriv | $0.00 | +300.0K | 370.0K | +429% | $0 |
| DI | 2024-05-16 | 2024-05-13 | RPRX | Hite Christopher | EVP, Vice COB | C - Cnv Deriv | $0.00 | -30.0K | 541 | -98% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Shares | 2024-05-13 | C | A | 300,000 | $0.00 | 370,000 | I By SCH Investment Partners LLC | — | — | (F2) The Reporting Person has agreed to retain and not sell Class A Ordinary Shares and RPI US LP Interests convertible into Class A Ordinary Shares representing approximately 928,800 Class A Ordinary Shares before February 2025 pursuant to an agreement by and between the Reporting Person and RP Management, LLC. This restriction is waivable under certain circumstances. |
| 2 | Derivative | LP interests in RPI US Partners 2019, LP | 2024-05-13 | C | D | 30,000 | $0.00 | 541 | I By SCH Investment Partners LLC | $0.00 · — to — | 300,000 Class A Ordinary Shares | (F2) The Reporting Person has agreed to retain and not sell Class A Ordinary Shares and RPI US LP Interests convertible into Class A Ordinary Shares representing approximately 928,800 Class A Ordinary Shares before February 2025 pursuant to an agreement by and between the Reporting Person and RP Management, LLC. This restriction is waivable under certain circumstances. (F3) Represents limited partnership interests in RPI US Partners 2019, LP ("RPI US LP Interests"). Each RPI US LP Interest can be exchanged for ten Class B Interests in Royalty Pharma Holdings, Ltd. ("Holdings") at any time and for no additional value, which exchange right does not expire until so converted. Each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged upon such exchange for one Class A Ordinary Share of the Issuer for no additional value. |